Annual EBITDA
-$36.37 M
-$7.00 M-23.81%
December 1, 2023
Summary
- As of February 8, 2025, OKUR annual EBITDA is -$36.37 million, with the most recent change of -$7.00 million (-23.81%) on December 1, 2023.
- During the last 3 years, OKUR annual EBITDA has fallen by -$7.00 million (-23.81%).
- OKUR annual EBITDA is now -23.81% below its all-time high of -$29.38 million, reached on December 1, 2022.
Performance
OKUR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$4.66 M
+$9.30 M+66.60%
September 30, 2024
Summary
- As of February 8, 2025, OKUR quarterly EBITDA is -$4.66 million, with the most recent change of +$9.30 million (+66.60%) on September 30, 2024.
- Over the past year, OKUR quarterly EBITDA has increased by +$16.22 million (+77.67%).
- OKUR quarterly EBITDA is now -121.65% below its all-time high of $21.55 million, reached on December 31, 2023.
Performance
OKUR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$6.76 M
+$16.22 M+70.58%
September 30, 2024
Summary
- As of February 8, 2025, OKUR TTM EBITDA is -$6.76 million, with the most recent change of +$16.22 million (+70.58%) on September 30, 2024.
- Over the past year, OKUR TTM EBITDA has increased by +$30.78 million (+81.99%).
- OKUR TTM EBITDA is now at all-time high.
Performance
OKUR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OKUR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.8% | +77.7% | +82.0% |
| 3 y3 years | -23.8% | +77.7% | +82.0% |
| 5 y5 years | -23.8% | +77.7% | +82.0% |
OKUR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.8% | at low | -121.7% | +77.7% | at high | +82.0% |
| 5 y | 5-year | -23.8% | at low | -121.7% | +77.7% | at high | +82.0% |
| alltime | all time | -23.8% | at low | -121.7% | +77.7% | at high | +82.0% |
OnKure Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.66 M(-66.6%) | -$6.76 M(-70.6%) |
| Jun 2024 | - | -$13.96 M(+44.3%) | -$22.99 M(+34.8%) |
| Mar 2024 | - | -$9.68 M(-144.9%) | -$17.05 M(+6.6%) |
| Dec 2023 | - | $21.55 M | -$15.99 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$36.37 M(+23.8%) | - | - |
| Sep 2023 | - | -$20.89 M(+160.2%) | -$37.54 M(+125.4%) |
| Jun 2023 | - | -$8.03 M(-6.9%) | -$16.65 M(+93.1%) |
| Mar 2023 | - | -$8.62 M | -$8.62 M |
| Dec 2022 | -$29.38 M | - | - |
FAQ
- What is OnKure Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for OnKure Therapeutics?
- What is OnKure Therapeutics annual EBITDA year-on-year change?
- What is OnKure Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for OnKure Therapeutics?
- What is OnKure Therapeutics quarterly EBITDA year-on-year change?
- What is OnKure Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for OnKure Therapeutics?
- What is OnKure Therapeutics TTM EBITDA year-on-year change?
What is OnKure Therapeutics annual EBITDA?
The current annual EBITDA of OKUR is -$36.37 M
What is the all time high annual EBITDA for OnKure Therapeutics?
OnKure Therapeutics all-time high annual EBITDA is -$29.38 M
What is OnKure Therapeutics annual EBITDA year-on-year change?
Over the past year, OKUR annual EBITDA has changed by -$7.00 M (-23.81%)
What is OnKure Therapeutics quarterly EBITDA?
The current quarterly EBITDA of OKUR is -$4.66 M
What is the all time high quarterly EBITDA for OnKure Therapeutics?
OnKure Therapeutics all-time high quarterly EBITDA is $21.55 M
What is OnKure Therapeutics quarterly EBITDA year-on-year change?
Over the past year, OKUR quarterly EBITDA has changed by +$16.22 M (+77.67%)
What is OnKure Therapeutics TTM EBITDA?
The current TTM EBITDA of OKUR is -$6.76 M
What is the all time high TTM EBITDA for OnKure Therapeutics?
OnKure Therapeutics all-time high TTM EBITDA is -$6.76 M
What is OnKure Therapeutics TTM EBITDA year-on-year change?
Over the past year, OKUR TTM EBITDA has changed by +$30.78 M (+81.99%)